Alpha Particle Therapy: Getting Closer to a Promising Treatment for Neuroendocrine Tumors Emerging research suggests that alpha particle therapy could revolutionize the field, offering higher precision and more potent tumor-killing effects while minimizing damage to surrounding tissues. University of Oxford #cancer #oncology
Inside Precision Medicine
图书期刊出版业
NY，New Rochelle 10,609 位关注者
Exclusive news, features, & analysis on the research, tools, regulations, and applications driving precision medicine.
关于我们
Driven by a rapid and exponentially growing market – one that is expected to be valued at more than $126 billion by 2025 – and our commitment to covering the full breadth of the revolutionary field of precision medicine, Clinical OMICs is now Inside Precision Medicine! Inside Precision Medicine is the only global media brand covering the full spectrum of precision medicine, taking a wide lens approach while bringing into sharp focus the many complex and interconnected issues that constitute the field. From our core areas of Translational Research, Molecular Diagnostics, Informatics, and Patient Care, to our expanded coverage of Disease Indications and Payer/Regulatory issues, our best-in-class content informs, educates, and enlightens our diverse audience of leading decision-makers.
- 网站
-
https://www.InsidePrecisionMedicine.com
Inside Precision Medicine的外部链接
- 所属行业
- 图书期刊出版业
- 规模
- 51-200 人
- 总部
- NY，New Rochelle
- 类型
- 上市公司
- 创立
- 2014
- 领域
- precision medicine、news、information、molecular diagnostics和personalized medicine
地点
-
主要
获取路线
US，New Rochelle，NY，10810
Inside Precision Medicine员工
动态
-
TIMPS May Have Promise for Brain Cancer This University of Nevada, Reno finding offers a promising strategy to combat the deadliest form of brain #cancer—glioblastoma multiforme (GBM).
-
Physical Activity Could Slow Alzheimer’s Disease Physical activity could delay cognitive decline and have a positive effect on multiple biomarkers of #Alzheimer’s, a large study at memory clinics in South Korea has revealed.
-
Stanford University Researchers Develop Bispecific Antibody to Overcome SARS-CoV-2’s Mutations The bispecific antibody showed it neutralized SARS-CoV-2 variants by targeting a pair of virus sites that are highly resistant to mutations.
-
Amyloid-beta Immunization Promotes Microglial Response to Alzheimer’s Disease The study from the Northwestern University - The Feinberg School of Medicine reveals how treatments like monoclonal antibodies and vaccines for ALS disease influence microglial responses.
-
New St. Jude Probe Uses PET to Diagnose Neuro Conditions The St. Jude Children's Research Hospital technique repurposes the drug edaravone, an antioxidant used to treat #ALS, as an imaging probe.
-
Researchers Identify Mutations Linked to Primary KRAS G12C Inhibitor Resistance Co-occurring primary mutations that could render KRAS G12C inhibitors ineffective have been identified in colorectal and pancreatic #tumors. Mayo Clinic
-
Cannabis-Derived Compound Could Provide Nonaddictive Pain Relief The compound, developed by Washington University School of Medicine in St. Louis and Stanford University researchers, mimics properties of a natural molecule found in #cannabis to relieve #pain, without causing addiction or mind-altering effects.
-
Genomic Research Ethnic Homogeneity Threatens Value of Genetic Testing Research has highlighted how the underrepresentation of people from non-European heritage in genomics research could lead to innocent gene variants being implicated in diseases. Garvan Institute of Medical Research
-
Parkinson’s Rate Set to Surge, Globally A new estimate suggests 25.2 million people will be living with Parkinson’s disease worldwide, according to a team of Chinese researchers. That’s an 11.2% increase from 2021 and largely due to population aging. #aging #parkinsons